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Approximately 20–25% of regular smokers report heavy drinking. Abstinent smokers are
five times as likely to experience a smoking lapse during drinking episodes. Current efforts
seek to improve treatments for this subgroup of heavy-drinking smokers. This study
tested the feasibility and acceptability of addressing alcohol use in a brief, single session
smoking cessation intervention (SMK+A) compared to smoking cessation counseling
only (SMK); these interventions were grounded in a motivational interview framework and
included personalized feedback, decisional balance, quit day setting, and tailored skills
building (e.g., breathing techniques, coping with urges, dealing with social pressures) to
maintain abstinence. Descriptive outcomes included reported helpfulness of intervention
skills, readiness to change scores, and feasibility of participant recruitment and retention.
We also assessed 7-day point prevalence of smoking cessation, and smoking and
drinking reduction at 1-month follow-up. Participants (N = 22) were community-based
treatment-seeking daily smokers (≥5 cigarettes/day) who were also heavy drinkers (≥14
drinks/week for men, ≥ 7 drinks/week for women; or ≥5 drinks on one episode in past
week for men, ≥4 for women). Twenty five percent of interested individuals were eligible
after initial phone screen, and all randomized participants were retained through follow
up. All skills demonstrated high acceptability (i.e., rated between moderately and very
helpful), and a significant proportion of participants in each condition reported taking
action to reduce cigarette smoking and/or alcohol use at 1-month post-quit. Three
participants in each condition (27.3%) attained bioverified (CO ≤ 4 parts per million
and cotinine ≤ 3 ng/mL) smoking quit at follow-up. Given the modified intervention’s
acceptability and flexibility, larger studies may help to elucidate this intervention’s effects
on readiness to change, smoking cessation, and alcohol reduction.
Keywords: heavy drinking smokers, brief behavioral counseling, smoking cessation, alcohol reduction,
motivational interviewing
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INTRODUCTION
Despite overall declines, cigarette smoking remains
prevalent with 15.1% of adults in the United States reporting
regular smoking, defined as smoking at least 100 cigarettes
during their lifetime and smoking at minimum several days a
week (1). One problematic comorbidity that may contribute
to the consistently high percentage of adult cigarette smoking
prevalence in the United States is the frequent co-use of alcohol
and cigarettes. Approximately 20–25% of regular smokers
report heavy drinking (2–4), and abstinent smokers are five
times as likely to experience a smoking lapse during drinking
episodes (5). While the literature has suggested that greater
alcohol use is associated with a greater likelihood of a failed
smoking cessation attempt (6, 7), the frequency of heavy
drinking (defined as >3 drinks on any day or ≥7 drinks per
week for women and >4 drinks on any day or ≥14 drinks
per week for men, according to the U.S. National Institute of
Alcohol Abuse and Alcoholism) in particular appears to be
more prognosticative of poor cessation outcomes than frequency
of drinking more generally across the overall continuum of
drinking levels (2, 5). Laboratory studies have shown that even
smokers who drink at moderate levels are less able to resist
smoking a cigarette after consuming alcohol, relative to a placebo
beverage (8). Therefore, efforts to address smoking cessation
among heavy drinking smokers may be more successful
by addressing both alcohol and smoking within the same
intervention.
The guidelines for smoking cessation counseling consistently
describe the combined risks of smoking and drinking (9)
and suggest that drinking reduction or abstinence should be
recommended in order to promote a successful quit attempt (10,
11). Nevertheless, specific strategies for helping heavy-drinking
smokers address their alcohol use in the context of a smoking
cessation trial have not been sufficiently evaluated and developed.
Recent research has recognized the need to concomitantly
address alcohol use in the context of smoking cessation,
particularly among smokers who are identified as heavy drinkers.
In the behavioral treatment literature, Kahler et al. (12)
conducted a randomized clinical trial of transdermal nicotine
patch with either a standard four-session smoking cessation
treatment (ST-only) or the standard treatment incorporating
brief alcohol intervention (ST-BI). The ST-only intervention
included addressing situations that represented a high risk
for relapse, as well as encouraging efforts to seek additional
treatment and support, while ST-BI incorporated normative
feedback regarding the participant’s smoking and drinking levels,
a discussion of alcohol as a relapse risk factor, and developing
drinking goals. Results revealed that participants in the ST-
BI condition reported 20% fewer drinks per week and greater
smoking abstinence, than individuals in the ST-only condition,
over the course of the 26-week follow-up (12); the investigators
noted, however, that lasting smoking cessation outcomes may
require additional treatment development. Similarly, a study
of tobacco quitline callers found that a brief 2-session alcohol
intervention for hazardous-drinking callers resulted in higher
smoking cessation rates (13), suggesting that expanding the
alcohol content of even brief counseling encounters can have
substantial impacts on smoking behavior.
One potential barrier for effective and broadly implemented
treatments for heavy-drinking smokers is that smoking and
drinking topics are often approached differently by treatment
providers. Within primary care settings, physicians dedicate
significantly greater amounts of time addressing smoking relative
to alcohol effects on health (14, 15). Thirty percent of individuals
are screened for an alcohol or drug use problem during a
primary care visit (16), whereas 80% of patients report an
evaluation of smoking (17). A qualitative study also found
that providers tended to provide more vague recommendations
regarding drinking patterns, in contrast to smoking-related
recommendations (18). Multiple barriers also prevent thorough
discussions about drinking, such as the sensitivity of alcohol
misuse as a discussion topic, the patient’s lack of awareness
of the severity of their drinking, and lack of availability of
evidence-based interventions (19). On the other hand, large-
scale programs that funnel patients toward appropriate levels
of alcohol and illicit substance use treatment, including brief
counseling (e.g., Screening, Brief Intervention, and Referral to
Treatment (SBIRT); (20), do not include treatments for nicotine
dependence. Importantly, heavy-drinking smokers frequently
perceive that their alcohol consumption increases their smoking,
and report a preference for an integrated treatment modality
(21). Therefore, there is a great need for interventions that
address comorbid tobacco and alcohol use across treatment
contexts, from multisession treatment regimens to brief face-to-
face encounters with healthcare providers.
In summary, heavy-drinking smokers represent a unique
subgroup of smokers for whom the available interventions may
not be optimal. Current efforts seek to improve upon the
standard of care for this sizeable and hard-to-treat subgroup
of smokers who drink heavily. Empirically validated brief
behavioral interventions have demonstrated short-term efficacy
in simultaneously reducing alcohol use and increasing smoking
cessation rates among heavy-drinking smokers. No study to date,
however, has consolidated these smoking cessation interventions
that address alcohol use into a single session of counseling.
Examining the impact of such an intervention on smoking and
drinking outcomes may be important for two reasons. First,
addressing substance use that frequently co-occurs increases
ecological validity and relevance of smoking intervention
content. Second, this single-session intervention may be
informative for emerging and versatile brief smoking/alcohol
treatments that can be delivered across multiple treatment
settings by different types of providers (22, 23). Such treatments
have been shown to be cost-effective, highly feasible, and
successful in reducing substance use (24).
To that end, this pilot study tested whether addressing
alcohol use during a brief, single session, smoking cessation
counseling (SMK+A) would be feasible and acceptable among
heavy drinking smokers as compared to smoking cessation
counseling only (SMK). These interventions were grounded in
a motivational interview framework and included personalized
feedback, decisional balance, quit day setting, and tailored
skills building, as such menu-based interventions are efficacious,
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acceptable, and feasible (25); further, the flexibility of the
menu of skills provided a pragmatic way to incorporate a
discussion of alcohol. Therefore, this study sought to test
the feasibility and acceptability of the tailored behavioral
intervention. Acceptability was assessed through participants’
subjective ratings of the usefulness of skills selected in the
intervention conditions, and Readiness to Change scores for
smoking and drinking behaviors at baseline and follow-up.
This study also provides descriptive information regarding
smoking and drinking outcomes, including bioverified 7-day
point prevalence of smoking cessation (i.e., abstinence for 7 days
prior to 1-month follow-up), consistent with recommendations
for smoking cessation studies (26, 27), as well as drinking
and smoking reduction at 1-month follow-up. Consistent with
principles of feasibility reporting for small trials (28), feasibility
was assessed through participant retention through follow up, as
well as consideration of the percentage of study completers to the
number of screened and eligible heavy-drinking smokers.
MATERIALS AND METHODS
Participants and Procedures
Participants (N = 22) were treatment-seeking smokers recruited
through community advertisements. These advertisements
described an opportunity to participate in a study of smoking
cessation counseling to help people quit. Interested individuals
contacted the lab to complete an initial phone screening to assess
substance use history and exclusionary medical and psychiatric
conditions; 247 individuals completed this initial screening.
Inclusion criteria were: (1) between 21 and 55 years old, (2)
treatment-seeking smokers without quit attempts in the past 3
months and who were willing to set a quit date in the 30 days
following the intervention visit, (3) daily smokers smoking at
least five cigarettes per day, verified by carbon monoxide (CO)
and cotinine levels, (4) current heavy drinking as defined by
the National Institute on Alcohol Abuse and Alcoholism (29),
including at least 14 drinks per week or greater than four drinks
on any day in the past week for men, and at least seven drinks per
week or greater than three drinks on any day in the past week for
women. Exclusion criteria included: (1) Having stopped smoking
for at least 3 months over the past year, (2) current regular use
of illicit drugs other than marijuana, and (3) history of psychotic
disorders.
Eligible individuals were invited to the laboratory to complete
informed consent procedures, bioverification [CO, cotinine,
and breath alcohol concentration (BrAC)] and the counseling
session. Participants also completed the following assessments at
this laboratory visit: 30-day Timeline Follow-Back for cigarette
smoking and alcohol consumption (TLFB) (30); Fagerstrom
Test for Nicotine Dependence (FTND) (31); and Alcohol
Use Disorders Identification Test (AUDIT-C) (32). All study
procedures were approved by the local Institutional Review
Board (IRB).
Study Design
Eligible participants were randomly assigned to one of two
counseling conditions: alcohol and smoking (SMK+A) condition
or smoking only (SMK) condition (each condition n = 11; see
FIGURE 1 | CONSORT diagram.
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Figure 1). Both conditions included motivational interviewing
and brief behavioral counseling that lasted 50min. Therapists
were advanced clinical psychology graduate students supervised
by a licensed clinical psychologist (LAR). During the counseling
session, participants’ motivation to quit smoking and reduce
drinking was assessed using a Readiness to Change ladder
[RTC; (33)]. Participants completed one 30-day follow-up session
after the counseling session to assess alcohol and cigarette
use, verified by CO and cotinine. At follow-up, participants
completed questionnaires assessing how frequently they had used
skills covered in the intervention (reported as number of times of
use per skill within the past 30-day period), and how helpful each
skill was in their cessation/reduction, based on a 5-point Likert
scale (1 = “Not Helpful”; 3 = “Somewhat Helpful”; 5=”Very
Helpful”), in addition to a follow-up RTC ladder. Participants
were paid $20 at follow-up for attending both the intervention
session and follow-up.
Interventions
The 50-min smoking cessation counseling (SMK & SMK-
A) interventions included four components that were based
on effective motivational interview-based smoking and alcohol
interventions (34–36). First, participants received personalized
feedback on their cigarette use, including information on the
number of cigarettes smoked daily, total number of smoking
years, money spent on cigarettes, and quit attempts. Second,
participants discussed pros and cons of smoking and quitting
(“decisional balance”), as well as potential obstacles for quitting
(e.g., cravings during specific times of the day). Third, participant
and therapist worked together to set a smoking quit date
on any day within the 30 days post-intervention. Lastly, a
tailored skills-building approach was undertaken in which the
therapist selected one skill (from a menu) for the participant,
consistent with principles of motivational interviewing and
brief behavioral counseling for substance use. The therapist’s
chosen skill was informed by the previous module discussing
obstacles to quitting; the chosen skill aimed to help participants
successfully cope with identified obstacles. Participants were
also encouraged to select another two skills based upon his/her
interests and goals. In the SMK condition, therapists selected
a non-alcohol related skill, and the Reduce Alcohol Use skill
was not an available skill for participants. However, in the
smoking cessation counseling plus alcohol (SMK+A) condition,
the therapist-selected skill was always the Reduce Alcohol Use
skill. Therapists provided brief psychoeducation on the selected
skills and encouraged participants to discuss and practice the
skills in session. Therapists then worked with the participants to
develop individualized plans that incorporated use of the skills
outside of the session. The following non-alcohol related skills
were available in the menu of options: (a) Get Support and
Encouragement, (b) Identify and Cope with Urges, (c) Relaxation
Techniques, (d) Gradual Cut Down, (e) Cigarette Refusal Skills,
(f) Medication Guide, (g) Contact Quit Hotline, and (h) Access
Online Resources.
For example, a participant in the SMK condition might
have chosen the skills “Identify and Cope with Urges” and
“Cigarette Refusal Skills,” in addition to the therapist’s choice
of “Medication Guide.” In this case, the therapist would begin
the skills component of the intervention with information about
abstinence- and cue-induced cravings, such as their temporary
and undulating nature. The participant would have then been
asked to identify recurrent situations in which they experienced
craving. The therapist and participant would work to develop
methods for coping with cravings, such as engaging in other
activities, avoiding certain situations, or “urge surfing” (i.e.,
sitting with rather than fighting smoking cravings). The therapist
and participant then wouldmove on to discuss the second chosen
skill, “Cigarette Refusal Skills,” which included a discussion on
how to effectively communicate the participant’s goals and needs
with friends/family, and strategies for coping with resistance
from others. Lastly, the skill of “Medication Guide” would be
discussed, which would include general education on the purpose
and function of the various approved medications for smoking
cessation [e.g., nicotine replacement therapy (NRT), buproprion]
and a discussion with the participant as to who to contact for
more information and how to obtain medications (e.g., primary
care physician, pharmacist).
The SMK+A condition was tailored to address alcohol
use in several ways. First, the SMK+A condition included
information on the participant’s drinking patterns (e.g., drinking
days per month and drinks per drinking day) during the
personalized feedback component. Second, during the pros and
cons discussion, participants in SMK+A additionally reviewed
the pros and cons of reducing alcohol use while quitting smoking.
Third, the therapist chose the “Reduce Alcohol Use” skill as one
of the three skills to discuss during the skill selection component
of the tailored intervention. This skill included education on the
co-reinforcing properties of smoking and alcohol, discussion on
identifying individualized high-risk situations that could lead to
heavy drinking, and helped the participant plan feasible ways to
reduce heavy drinking and smoking, such as staggering drinks
at longer intervals, limiting cash to create a spending limit, and
reducing availability of cigarettes during social drinking. Other
than the addition of the Reduce Alcohol Use Skill, all skill items
on the menu were identical to the SMK condition.
Analytic Plan
In accordance with NIH policies for and limitations of
small feasibility trials in generating accurate and reliable
effect sizes [NIH NOT-OD-16-149; (37, 38)], null hypothesis
significance tests are not reported for clinical outcomes. T-
tests and chi-square tests assessed potential demographic, skill
use/acceptability, and substance use baseline differences between
participants in each condition. Frequency of skill use and ratings
of skill helpfulness are reported as indices of intervention
acceptability, and participant retention and percentage of eligible
participants among interested individuals were assessed for
feasibility. Cessation based on 7-day point-prevalence at 30-day
follow-up was operationalized as having a CO reading ≤ 4 parts
per million (PPM) and cotinine levels ≤ 3 ng/mL, consistent
with smoking cessation studies in the United States (39, 40).
Also reported are pre-intervention and 1-month follow-up TLFB
drinks per drinking day, number of heavy drinking days (greater
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than three drinks per day for women and four drinks per day for
men), and RTC scores for smoking and alcohol use behaviors.
RESULTS
Demographic, behavioral, and substance use characteristics are
presented in Table 1. Chi-square and t-tests revealed that there
were no significant differences in any of these variables between
the two intervention groups (ps= 0.36–0.68).
Feasibility
In total, ∼25% of interested individuals were eligible for
this study after initial phone screening. Of the 61 eligible
individuals after the phone screening, 22 participants came
to the laboratory for the in-person assessment and were
randomized. This ratio of eligible to enrolled participants
is consistent with recruitment rates in previous studies
of treatment-seeking smokers (41). All 22 randomized
participants were retained through 1 month follow-up
(i.e., 100% retention rate). Together, the enrollment and
retention rates suggest that this intervention is feasible
in the context of an outpatient research clinic and in a
community sample of treatment-seeking heavy drinking
smokers. Transportability and feasibility in other health
care settings, such as primary care clinics, warrant further
investigation.
Acceptability
Participants chose a quit date that ranged from 1 to 26 days post-
intervention (M= 12.18, SD= 7.40), with no differences between
intervention groups. Participants demonstrated variability in
how frequently they used the skills discussed during the
counseling session over the 30 days post-quit (0–300 instances;
see Table 2). The most frequently utilized skill was breathing
techniques and least frequently utilized skills were medications
that reduce craving and quit hotlines. Within the SMK+A
condition, participants reported considering the impact of
their alcohol use approximately five times during the previous
30 days. On average, participants reported that most skills
were between moderately and very helpful. Descriptively,
participants rated “Get Support and Encouragement” and
“Addressing Alcohol Use” as the most helpful skills, and
TABLE 1 | Sample characteristics (N = 22).
Variable Full sample SMKa SMK + Ab
Age—M (SD) 38.5 (11.9) 40.1 (12.0) 36.9 (12.0)
Gender—N (%)
Men 15 (71.4) 8 (72.7) 7 (63.6)
Women 7 (31.8) 3 (27.3) 4 (36.4)
Race—N (%)
White 8 (36.4) 4 (36.4) 4 (36.4)
Black 10 (45.5) 4 (36.4) 6 (54.5)
Latino 6 (27.3) 3 (27.3) 3 (27.3)
Substance use—M (SD), range
Fagerstrom Test for Nicotine 5.6 (1.6), 2–9 5.7 (1.6), 2–8 5.5 (1.7), 3–9
Dependence (FTND)
Cigarette Smoking (30-day TLFB)
Baseline cigarettes per day 14.2 (7.8), 5–40 12.6 (5.0), 5–20 15.9 (9.8), 7.6–40
Follow-Up cigarettes per day 2.1 (2.5), 0–9.4 2.2 (2.2), 0–6 1.9 (2.9), 0–9.4
Alcohol Use Disorders 14.3 (8.4), 4–34 13.9 (6.7), 6–24 14.7 (10.1), 4–34
Identification Test (AUDIT)
Alcohol Use (30-day TLFB)
Baseline drinks per drinking day 5.8 (4.9), 1.5–22 4.7 (2.3), 2.8–10.8 6.7 (6.3), 1.5–22
Follow-Up drinks per drinking day 3.5 (2.1), 1–8.7 3.5 (1.0), 2–5.3 3.5 (2.8), 0.3–8.7
Baseline heavy drinking days 11.3 (9.5), 0–30 11.1 (8.6), 0–27 11.5 (10.7), 0–30
Follow-Up heavy drinking days 3.2 (3.6), 0–13 3.8 (4.4), 0–13 2.6 (2.7), 0–9
Readiness to change—alcohol
Baseline 5.9 (3.0), 0–10 5.1 (3.1), 1–10 6.6 (2.8), 0–10
Follow-Up 6.4 (3.1) 0–10 5.3 (3.6), 0–10 7.7 (1.8), 5–10
Readiness to change—smoking
Baseline 6.4 (1.7), 2–9 6.2 (1.9), 2–8 6.6 (1.5), 5–9
Follow-Up 7.3 (2.2), 2–10 6.8 (2.5), 2–10 7.8 (1.9), 5–10
aSMK = Smoking only intervention condition.
bSMK+A = Smoking and alcohol intervention condition.
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TABLE 2 | Utility of smoking cessation skills discussed in the brief counseling
condition.
Skill How often did you
use this skill in the
last 30 days?
M (SD), range
How helpful was this
skill in the last 30
days?
M (SD), range
Breathing techniques 34.4 (70.2), 0–300 3.8 (1.3), 1–5
Identify and coping with
urges
17.4 (14.6), 0–50 3.8 (1.3), 1–5
Get support and
encouragement
14.3 (12.6), 0–30 4.0 (1.4), 1–5
Gradual
reduction/cutting down
13.3 (13.0), 0–35 3.9 (1.2), 1–5
Dealing with social
pressures
12.9 (14.2), 0–45 3.8 (1.1), 1–5
Addressing alcohol
usea
4.7 (7.4), 0–25 4.1 (1.4), 1–5
Web resources 2.0 (5.5), 0–20 3.3 (1.7), 1–5
Medication guide 2.0 (3.8), 0–15 2.9 (1.7), 1–5
Quitlines 1.0 (2.3) 0–8 3.2 (1.8), 1–5
aThis item was only completed by participants randomly assigned to the smoking
cessation + drinking reduction counseling condition (SMK+A).
rated “Medication Guide” and “Quitlines” as the least helpful
skills.
At baseline, 6 of 11 SMK+A and 5 of 11 SMK participants
reported a RTC smoking score ≥7, indicating intentions that
range from being ready to quit smoking to starting to reduce
cigarette consumption in preparation for quit. Such scores
correspond with Preparation and Action stages of change (42).
For alcohol use, 6 of 11 SMK+A and 4 of 11 SMK reported
RTC alcohol scores greater than or equal to 7. One participant
in each condition reported RTC alcohol scores of 10, indicating
stable reductions in alcohol use that the participants wished to
maintain.
At 1-month follow-up, 7 of 11 SMK+A and 4 of 11
SMK participants reported a RTC smoking score greater
than or equal to 7, with 3 participants in each condition
reporting scores of 10, or a desire to maintain smoking
abstinence. Additionally, 2 participants in SMK+A reported
RTC smoking scores of 9, indicating reductions in cigarette
consumption in preparation for abstinence. For alcohol use, 6
of 11 SMK+A and 5 of 11 SMK participants reported a RTC
alcohol score ≥7. Of these, 5 SMK+A and 3 SMK participants
reported RTC scores of either 9 or 10; such participants had
taken some action to reduce their drinking, and expressed a
desire to cut back further and/or maintain these changes in
drinking.
Smoking and Alcohol Outcomes
A total of three participants in each intervention condition
met criteria for bioverified 7-day point-prevalence smoking
abstinence at 1-month follow-up. Visual comparisons by
intervention group are available for 30-day TLFB cigarettes per
day (see Figure 2A, drinks per drinking day (see Figure 2B), and
heavy drinking days (see Figure 2C).
FIGURE 2 | Comparisons over time of 30-day TLFB cigarettes per day (A),
drinks per drinking day (B), and heavy drinking days (C). Error bars indicate
standard error.
DISCUSSION
The current study examined acceptability and feasibility of a
modified brief counseling intervention that incorporates alcohol
reduction skills for heavy drinking smokers. Descriptive evidence
supports both acceptability and feasibility of the modified
intervention. One quarter of interested individuals were eligible
after initial phone screening as treatment-seeking heavy drinking
smokers, corroborating high comorbidity rates of cigarette
smoking and drinking and potential applicability of the brief
intervention for significant swaths of smoking populations.
Combined with low dropout rate (0%) after randomization, these
Frontiers in Psychiatry | www.frontiersin.org 6 August 2018 | Volume 9 | Article 362
Lim et al. Heavy Drinking Smokers
results demonstrate that recruitment and longitudinal retention
of this subgroup of smokers for this brief intervention is feasible.
Acceptability was also demonstrated in this study through
participant endorsement of skill utility. Addressing alcohol use
in the SMK+A condition demonstrated the highest self-reported
helpfulness score in achieving cessation and reduction goals.
Although participants endorsed a range for how frequently
they utilized each of the skills, the skills relating to utilization
of quitlines and medications were reported to be the least
helpful resources, and demonstrated the lowest frequency of
utilizing these resources. Previous studies have documented the
underutilization of these effective treatments among smokers
(43, 44). Potential reasons for this underutilization include
logistical barriers (i.e., monetary costs) (43), misconceptions
about pharmacological treatments (45), and beliefs about quitting
smoking unassisted (46). Therefore, if these results are replicated
in larger studies, there may be potential benefit in discussing
additional barriers regarding the utilization of these resources
when clinically indicated.
Regarding RTC, a significant proportion of participants in
both conditions reported sustaining or developing an interest in
reducing cigarette smoking at 1 month follow-up. Participants in
both conditions also expressed an elevated interest in reducing
alcohol use, with over half of the participants in the SMK+A
condition reporting that they have already taken steps to
reduce alcohol use at 1 month follow-up. Previous studies have
found that brief motivational interventions produce immediate
changes in motivation for reducing cigarette use, but that these
effects dissipate after 1 month (47). Though parametric pre-post
comparisons were not made in this study due to small sample
size, future studies that examine potential effects of the modified
intervention on RTC for alcohol reduction are warranted; should
such an effect be supported, it may be critical to take advantage
of short-term increases in motivation for change. Supplementary
assistance such as physician support (48) may be particularly
beneficial in sustaining cessation/reduction attempts.
While the primary aim of the study was feasibility and
treatment development, preliminary data were obtained and
revealed that a meaningful number of participants successfully
quit smoking following the brief intervention, with 6 out of 22
participants (27.3%) reporting successful biochemically verified
quit at 1-month follow-up across both conditions. It is also
promising that no participants in either condition reported
an increase in cigarette smoking or alcohol use at follow-up.
Previous work has suggested that level of alcohol consumption
moderates the effects of smoking interventions with integrated
alcohol components, such that moderate drinkers appear to
benefit more from these interventions than heavy drinkers (12).
Further, individuals with low levels of alcohol use disorder and
lower alcohol consumption reduce their drinking even after
brief counseling (49), suggesting the present intervention may
be particularly relevant for heavy-drinking smokers with lower
alcohol consumption and use disorder severity.
The most unique strengths of this intervention include its
brief duration, practicality, feasibility, low cost, and the ease with
which it can be incorporated within various types of settings
(e.g., primary care, residential substance use treatment, urgent
care) and administered by myriad health service professionals
(e.g., nurses, counselors, tobacco treatment specialists, chemical
dependency counselors). Limitations of the current study
include its small sample size that preclude reliable effect size
estimates and reinforce the need for replication, the absence
of a control condition to control for quit rates attributable to
study enrollment, and lack of quantitative assessment regarding
participant’s chosen smoking cessation skills. Future studies
that examine and further develop these treatments in multiple
settings, particularly in the context of combined treatments, may
be important to understand whether this intervention provides
compounded benefits in sustaining motivation for smoking
and alcohol reduction. For instance, though there are mixed
results regarding the efficacy of naltrexone in increasing smoking
abstinence and decreasing alcohol use (50, 51), there is emerging
evidence that a combination of naltrexone and varenicline
may reduce use of both cigarettes and alcohol among heavy
drinking smokers (52). Incorporation of brief counseling sessions
into studies of these effective medications may therefore be a
promising treatment venue to reinforce such healthy behavior
change for these individuals in different treatment settings.
CONCLUSIONS
This initial study provides preliminary feasibility and
acceptability data on a brief counseling intervention for smoking
cessation targeted for heavy-drinking smokers. Discussing the
use of alcohol reduction in the context of motivational-interview
based smoking cessation counseling was overall deemed
acceptable and feasible. Larger studies will help to elucidate this
intervention’s effects on readiness to change, smoking cessation,
and alcohol reduction. Such work that builds upon current
practice guidelines for heavy-drinking smokers may be crucial
for this difficult to treat population.
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